Skip to main content
Fig. 3 | Renal Replacement Therapy

Fig. 3

From: Amelioration of fatigue in chronic dialysis patients with dialysis solution employing electrolyzed water containing molecular hydrogen (H2) and its association with autonomic function balance

Fig. 3

Serial changes in visual analog scale scores for fatigue on dialysis day (a) and dialysis-free day (b). *p < 0.05 versus Pre; **p < 0.01 versus Pre VAS on HD day (mean ± SD), Group-A: 6.0 ± 1.4 (pre), 5.2 ± 2.2 (2w), 4.3 ± 2.8 (4w), 4.2 ± 2.7 (8w); Group-B: 7.2 ± 1.6 (pre), 6.4 ± 1.2 (2w), 6.3 ± 1.9 (4w), 5.0 ± 3.0 (8w); Group-C: 1.4 ± 1.5 (pre), 3.2 ± 2.5 (2w), 2.5 ± 2.2 (4w), 2.2 ± 2.4 (8w). Comparisons, pre: A versus C; B versus C: p < 0.001, respectively; 2w: A versus C: p = 0.001, B versus C: p < 0.001; 4w: A versus C: p = 0.002, B versus C: p < 0.001; 8w: A versus C: p = 0.003, B versus C: p = 0.006. VAS on HD-free day (mean ± SD), Group-A: 1.3 ± 1.0 (pre), 2.5 ± 1.9 (2w), 1.8 ± 2.1 (4w), 1.1 ± 1.4 (8w); Group-B: 5.7 ± 1.6 (pre), 3.6 ± 1.9 (2w), 3.4 ± 2.3 (4w), 1.7 ± 2.1 (8w); Group-C: 0.4 ± 0.7 (pre), 2.1 ± 1.9 (2w), 1.0 ± 1.1 (4w), 0.6 ± 1.0 (8w). Comparisons, pre: A versus C; A versus B; B versus C: p < 0.001, respectively; 2w: NS; 4w: B versus C: p < 0.001, A versus B: p = 0.034; 8w: B versus C: p = 0.040

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us